Cwm Cut Pfizer (PFE) Position; Cobalt Has 0.93 Sentiment

June 20, 2017 - By Stephen Andrade

CBIZ, Inc. is engaged in the professional services business. The company has market cap of $821.29 million. The Firm operates its professional services business through acquiring and integrating accounting and financial service providers, group health benefits consulting firms, property and casualty brokerage firms, payroll service providers, and valuation and other service firms throughout the United States. It has a 18.89 P/E ratio. The Company’s divisions include Financial Services, Benefits and Insurance Services, National Practices, and Corporate and Other.

Cwm Llc decreased Pfizer Inc (PFE) stake by 18.76% reported in 2016Q4 SEC filing. Cwm Llc sold 54,125 shares as Pfizer Inc (PFE)’s stock declined 3.45%. The Cwm Llc holds 234,318 shares with $7.61M value, down from 288,443 last quarter. Pfizer Inc now has $198.79 billion valuation. The stock increased 0.76% or $0.25 during the last trading session, reaching $33.22. About 3 shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since June 20, 2016 and is downtrending. It has underperformed by 19.46% the S&P500.

Among 20 analysts covering Pfizer (NYSE:PFE), 7 have Buy rating, 1 Sell and 12 Hold. Therefore 35% are positive. Pfizer had 45 analyst reports since July 29, 2015 according to SRatingsIntel. As per Friday, October 2, the company rating was upgraded by Morgan Stanley. The stock has “Equal-Weight” rating by Barclays Capital on Tuesday, December 1. The stock of Pfizer Inc. (NYSE:PFE) earned “Outperform” rating by Credit Suisse on Monday, May 9. The rating was reinitiated by JP Morgan on Thursday, April 7 with “Overweight”. The firm has “Neutral” rating by Morgan Stanley given on Friday, April 7. As per Monday, May 2, the company rating was maintained by Leerink Swann. The firm earned “Hold” rating on Wednesday, November 2 by Argus Research. The rating was maintained by S&P Research with “Hold” on Wednesday, October 28. The firm has “Hold” rating by Societe Generale given on Wednesday, April 6. The stock has “Buy” rating by Piper Jaffray on Friday, August 14.

Investors sentiment decreased to 1.13 in Q4 2016. Its down 0.05, from 1.18 in 2016Q3. It dropped, as 60 investors sold PFE shares while 672 reduced holdings. 115 funds opened positions while 711 raised stakes. 4.12 billion shares or 1.11% more from 4.08 billion shares in 2016Q3 were reported. Palo Cap holds 19,327 shares. Johnson Counsel Incorporated stated it has 164,431 shares. Oppenheimer Inc reported 751,877 shares. Moreover, Conestoga Capital Advisors Ltd Llc has 0.04% invested in Pfizer Inc. (NYSE:PFE). Interocean Ltd Liability accumulated 0.07% or 9,524 shares. Fisher Asset Management Ltd Liability Corp owns 32.20 million shares. Lombard Odier Asset Mgmt (Europe) Limited reported 77,666 shares or 0.91% of all its holdings. National Pension Service invested in 0.87% or 3.93M shares. Baxter Bros holds 21,183 shares or 0.22% of its portfolio. Hawkins Lp holds 149,000 shares or 1.55% of its portfolio. First Citizens National Bank & has invested 1.31% in Pfizer Inc. (NYSE:PFE). Toronto Dominion Bankshares reported 1.15 million shares stake. Moreover, Annex Advisory Svcs Ltd Com has 0.23% invested in Pfizer Inc. (NYSE:PFE) for 29,767 shares. Choate Inv Advsrs invested 0% of its portfolio in Pfizer Inc. (NYSE:PFE). Nordea Inv Management Ab has invested 2.4% in Pfizer Inc. (NYSE:PFE).

Since February 27, 2017, it had 0 buys, and 5 insider sales for $5.16 million activity. The insider HILL CHARLES H sold $1.23 million. $2.02 million worth of stock was sold by Dolsten Mikael on Monday, February 27. LANKLER DOUGLAS M had sold 20,000 shares worth $693,200. On Friday, March 10 the insider JOHNSON RADY A sold $153,855.

Cwm Llc increased Oracle Corp (NYSE:ORCL) stake by 127,852 shares to 644,172 valued at $24.77 million in 2016Q4. It also upped Mastercard Incorporated (NYSE:MA) stake by 20,365 shares and now owns 288,138 shares. Henry Jack & Assoc Inc (NASDAQ:JKHY) was raised too.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on August, 1. They expect $0.65 EPS, up 1.56% or $0.01 from last year’s $0.64 per share. PFE’s profit will be $3.89B for 12.78 P/E if the $0.65 EPS becomes a reality. After $0.69 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -5.80% negative EPS growth.

The stock increased 0.33% or $0.05 during the last trading session, reaching $15.2. About shares traded. CBIZ, Inc. (CBZ) has risen 47.49% since June 20, 2016 and is uptrending. It has outperformed by 30.79% the S&P500.

Since January 1, 0001, it had 0 insider purchases, and 13 sales for $4.10 million activity.

P2 Capital Partners Llc holds 2.53% of its portfolio in CBIZ, Inc. for 1.41 million shares. Skyline Asset Management Lp owns 2.15 million shares or 1.95% of their US portfolio. Moreover, Cardinal Capital Management Llc Ct has 1.67% invested in the company for 2.84 million shares. The Florida-based Private Capital Management Llc has invested 1.22% in the stock. Opus Capital Group Llc, a Ohio-based fund reported 566,608 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: